Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 in 11 adults. Moreover, the rapid growth of this disease has resulted in a high incidence of diabetic kidney disease (DKD), which, together with hypertension, is the main cause of chronic kidney diseas...

Full description

Autores:

D’Marco, Luis
Puchades, María Jesús
Gandía, Lorena
Forquet, Claudia
Giménez-Civera, Elena
Panizo, Nayara
Reque, Javier
Juan-García, Isabel
Bermúdez, Valmore
Gorriz, José Luis

Tipo de recurso:

Fecha de publicación:

2021

Institución:

Universidad Simón Bolívar

Repositorio:

Repositorio Digital USB

Idioma:

eng

OAI Identifier:

oai:bonga.unisimon.edu.co:20.500.12442/9655

Acceso en línea:

https://hdl.handle.net/20.500.12442/9655
https://doi.org/10.17925/EE.2021.17.2.84

Palabra clave:

Chronic kidney disease
cardiovascular diseases
diabetic nephropathies
finerenone

Rights

openAccess

License

Attribution-NonCommercial-NoDerivatives 4.0 Internacional